| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |